Epidemiological Molecular Study of Metallo Beta Lactamases in Acinetobacter Baumannii at a Tertiary Care Hospital
Authors/Creators
- 1. Tutor, Department of Microbiology, DMCH, Laheriasarai, Darbhanga
- 2. Associate Professor, Department of Microbiology, DMCH, Laheriasarai, Darbhanga
- 3. Professor, Department of Microbiology, DMCH, Laheriasarai, Darbhanga
- 4. Professor & Head, Department of Microbiology, DMCH, Laheriasarai, Darbhanga
Description
Background and Objectives: Carbapenem resistance mediated by metallo beta lactamases (MBL) in Acinetobacter baumannii is a global challenge due to its rapid spread and limited therapeutic options. To determine the prevalence of MBL in A. baumannii isolates in hospitalized patients by both phenotypic and genotypic methods. Materials and Methods: The clinical samples were collected from in patients and subcultured on routine culture media for growth. Identification of bacteria along with antimicrobial sensitivity testing was done by VITEK -2 Compact (bioMerieux). Antibiotics that were not tested by VITEK-2 were tested manually by Kirby-Bauer disk diffusion method according to CLSI 2017 and EUCAST 2016 guidelines. The isolates which were resistant to carbapenem (imipenem and/ or meropenem) were tested by phenotypic (imipenem-EDTA combined disk method) and genotypic method for presence of common metallo beta lactamases genes (blaIMP, blaNDM, blaGIM, blaVIM, blaSPM and blaSIM). Conclusion: The prevalence of MBL in carbapenem resistant isolates of A. baumannii was 87.7%. blaNDM was the most common gene detected. No significant difference was found in the ability of phenotypic and genotypic methods for MBL detection. The resistance rate of the A. baumannii is high for most antibiotics except for polymyxins (E&B) and tigecycline.
Abstract (English)
Background and Objectives: Carbapenem resistance mediated by metallo beta lactamases (MBL) in Acinetobacter baumannii is a global challenge due to its rapid spread and limited therapeutic options. To determine the prevalence of MBL in A. baumannii isolates in hospitalized patients by both phenotypic and genotypic methods. Materials and Methods: The clinical samples were collected from in patients and subcultured on routine culture media for growth. Identification of bacteria along with antimicrobial sensitivity testing was done by VITEK -2 Compact (bioMerieux). Antibiotics that were not tested by VITEK-2 were tested manually by Kirby-Bauer disk diffusion method according to CLSI 2017 and EUCAST 2016 guidelines. The isolates which were resistant to carbapenem (imipenem and/ or meropenem) were tested by phenotypic (imipenem-EDTA combined disk method) and genotypic method for presence of common metallo beta lactamases genes (blaIMP, blaNDM, blaGIM, blaVIM, blaSPM and blaSIM). Conclusion: The prevalence of MBL in carbapenem resistant isolates of A. baumannii was 87.7%. blaNDM was the most common gene detected. No significant difference was found in the ability of phenotypic and genotypic methods for MBL detection. The resistance rate of the A. baumannii is high for most antibiotics except for polymyxins (E&B) and tigecycline.
Files
IJPCR,Vol16,Issue8,Article206.pdf
Files
(342.8 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:b518be4fa753dac4998813bb04819e0b
|
342.8 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-08-17
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue8,Article206.pdf
- Development Status
- Active
References
- 1. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006;12(9):826- 36. 2. Goudarzi H ME, Ghalavand Z, Vala MH, Mirjalali H, Hashemi A, et al. Molecular Detection of Metallo- Beta-Lactamase genes in Clinical Isolates of Acinetobacter baumannii. J Pure Appl Microbio. 2015; 9:145-51. 3. Vila J, Martí S, Sanchez-Céspedes J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother. 2007;59(6):1210-5. 4. Aksoy MD, Çavuşlu Ş, Tuğrul HM. Investigation of metallo beta lactamases and oxacilinases in carbapenem resistant Acinetobacter baumannii strains isolated from inpatients. Balkan Med J. 2015;32(1):79-83. 5. Alkasaby NM, El Sayed Zaki M. Molecular study of Acinetobacter baumannii isolates for Metallo-β- lactamases and extended-spectrumβ-lactamases genes in intensive care unit, Mansoura University Hospital, Egypt. Int J Microbiol. 2017;2017. 6. Karthika RU, Rao RS, Sahoo S, Shashikala P, Kanungo R, Jayachandran S, et al. Phenotypic and genotypic assays for detecting the prevalence of metallo-β- lactamases in clinical isolates of Acinetobacter baumannii from a South Indian tertiary care hospital. J Med Microbiol. 2009;58(4):430-5. 7. Purohit M, Mendiratta D, Deotale V, Madhan M, Manoharan A, Narang P. Detection of metallo-β- lactamases producing Acinetobacter baumannii using microbiological assay, disc synergy test and PCR. Indian J Med Microbio. 2012;30(4):456. 8. Singla P, Sikka R, Deep A, Chaudhary U. Phenotypic Detection and Prevalence of Metallo ΒLactamases (Mbls) In Carbapenem Resistant Isolates Of Acinetobacter Species At A Tertiary Care Hospital In North India. Int J Pharm Med Bio Sci. 2013; 2:85-91. 9. Pandya Y, Singh S, Badodariya D, Shethwala N. Metallo-B-Lactamase Producing Clinical Isolates of Acinetobacter baumannii AndPseudomonas aeruginosa In A Teaching Hospital Of Rural Gujarat- India. Natl J Integr Res Med. 2016;7(6). 10. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 2017; twenty-seven edition - M100-S26. 11. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. 2016; Version 6.0. 12. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, ChongY. Imipenem-EDTA disk method for differentiation of metallo-β-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2002;40(10):3798-801. 13. Manoharan A, Chatterjee S, Mathai D, Group SS. Detection and characterization of metallo beta lactamases producing Pseudomonas aeruginosa. Indian J Med Microbiol. 2010;28(3):241. 14. Mohanam L, Menon T. Coexistence of metallobeta- lactamase-encoding genes in Pseudomonas aeruginosa. Indian J Med Res. 2017;146(Suppl 1):S46. 15. Shenoy KA, Jyothi E, Ravikumar R. Phenotypic identification & molecular detection of blaNDM-1 gene in multidrug resistant Gramnegative bacilli in a tertiary care centre. Indian J Med Res. 2014;139 (4):625. 16. Castanheira M, Toleman MA, Jones RN, Schmidt FJ, Walsh TR. Molecular characterization of a β- lactamase gene, blaGIM-1, encoding a new subclass of metallo-β-lactamase. Antimicrob Agents Chemother. 2004; 48(12): 4654-61. 17. Khajuria A, Praharaj AK, Kumar M, Grover N. Molecular characterization of carbapenem resistant isolates of Acinetobacter baumannii in an intensive care unit of a tertiary care centre at central India. J Clin Diagn Res. 2014;8(5): DC38. 18. Gomaa FA-ZM, Tawakol WM, El-Azm A, Fatma I. Phenotypic and Genotypic Detection of Some Antimicrobial Resistance Mechanisms among Multidrug-Resistant Acinetobacter Baumannii Isolated from Immunocompromised Patients in Egypt. Egypt J Med Microbiol. 2014;38(3276):1-14. 19. Saranya A SM, Aboody M. Prevalence of Metallo-Β- Lactamases in Carbapenem Resistant Acinetobacter baumannii Isolated from Tracheal Secretions. Int J Recent Sci Res. 2017;8(1):15197-202. 20. Nandy S, Asthana AK, Madan M. Molecular Characterization of Metallo Beta Lactamase Producing Clinical Isolates of Acinetobacter. IJCMR. 2015:2(4).